111 Inc (NASDAQ:YI) — Market Cap & Net Worth
Market Cap & Net Worth: 111 Inc (YI)
111 Inc (NASDAQ:YI) has a market capitalization of $22.92 Million ($22.92 Million) as of June 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #24693 globally and #5212 in its home market, demonstrating a 0.23% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying 111 Inc's stock price $4.41 by its total outstanding shares 5196964 (5.20 Million). Review YI total debt and obligations to assess the company's total debt and financial obligations.
111 Inc Market Cap History: 2018 to 2026
111 Inc's market capitalization history from 2018 to 2026. Data shows change from $31.91 Million to $22.92 Million (-13.66% CAGR).
Index Memberships
111 Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Composite
IXIC
|
$40.74 Trillion | 0.00% | #2324 of 3165 |
Weight: 111 Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
111 Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how 111 Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
111 Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $31.91 Million | $1.79 Billion | -$380.09 Million | 0.02x | N/A |
| 2019 | $34.98 Million | $3.95 Billion | -$499.61 Million | 0.01x | N/A |
| 2020 | $36.12 Million | $8.20 Billion | -$456.53 Million | 0.00x | N/A |
| 2021 | $18.19 Million | $12.43 Billion | -$669.81 Million | 0.00x | N/A |
| 2022 | $15.69 Million | $13.52 Billion | -$416.88 Million | 0.00x | N/A |
| 2023 | $8.06 Million | $14.95 Billion | -$392.69 Million | 0.00x | N/A |
| 2024 | $3.24 Million | $14.40 Billion | -$64.74 Million | 0.00x | N/A |
| 2025 | $13.30 Million | $12.21 Billion | -$16.84 Million | 0.00x | N/A |
Competitor Companies of YI by Market Capitalization
Companies near 111 Inc in the global market cap rankings as of June 18, 2026.
Key companies related to 111 Inc by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #271 globally with a market cap of $93.74 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #539 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #642 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1154 globally with a market cap of $22.95 Billion USD ( AU$32.44 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #271 | McKesson Corporation | NYSE:MCK | $93.74 Billion | $779.80 |
| #539 | Cencora Inc. | NYSE:COR | $50.53 Billion | $277.09 |
| #642 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $226.28 |
| #1154 | Sigma Healthcare Ltd | AU:SIG | $22.95 Billion | AU$2.81 |
111 Inc Historical Marketcap From 2018 to 2026
Between 2018 and today, 111 Inc's market cap moved from $31.91 Million to $ 22.92 Million, with a yearly change of -13.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $22.92 Million | +72.27% |
| 2025 | $13.30 Million | +310.91% |
| 2024 | $3.24 Million | -59.81% |
| 2023 | $8.06 Million | -48.68% |
| 2022 | $15.69 Million | -13.71% |
| 2021 | $18.19 Million | -49.64% |
| 2020 | $36.12 Million | +3.27% |
| 2019 | $34.98 Million | +9.61% |
| 2018 | $31.91 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of 111 Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $22.92 Million USD |
| MoneyControl | $22.92 Million USD |
| MarketWatch | $22.92 Million USD |
| marketcap.company | $22.92 Million USD |
| Reuters | $22.92 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About 111 Inc
111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education,… Read more